Creating a new rat model to study a rare genetic brain disease
Novel Knock in Mutation Rat Model for CARASIL
This study is creating a special type of rat to help us learn more about a rare brain condition called CARASIL, so we can better understand how it affects thinking and movement, and hopefully find new ways to help people with this disease.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rhode Island NIH-funded |
| Lab location | 1 site (Kingston, United States) |
| Project ID | NIH-10518554 on NIH RePORTER |
What this research studies
This research focuses on developing a novel rat model to investigate cerebral small vessel diseases (CSVD), particularly a rare condition known as CARASIL. By using genetic modifications, the researchers aim to replicate the disease's characteristics in rats, which will help in understanding its progression and effects on cognitive function. The study will utilize advanced imaging techniques to observe brain changes and assess the impact of the disease on behavior and motor skills. This model could provide valuable insights into potential treatments and interventions for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with CARASIL or those exhibiting symptoms of cerebral small vessel diseases.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to CSVD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients suffering from CARASIL and related cognitive impairments.
How similar studies have performed: While research on CSVD is ongoing, the specific approach of creating a novel rat model for CARASIL is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
Kingston, United States
- University of Rhode Island — Kingston, United States (Active)
Researchers
- Principal investigator: Van Nostrand, William E. — University of Rhode Island
- Study coordinator: Van Nostrand, William E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.